Skip to main content
. Author manuscript; available in PMC: 2016 Sep 1.
Published in final edited form as: AIDS Behav. 2015 Sep;19(9):1599–1608. doi: 10.1007/s10461-014-0974-x

Table II.

Patient Characteristics at Enrollment According to Cohort, Age at HIV diagnosis, and MSM Population

Entire Population MSMa Population

CCASAnetb VCCCc CCASAnet MSM VCCC MSM

< 25 years ≥ 25 years < 25 years ≥ 25 years < 25 years ≥ 25 years < 25 years ≥ 25 years
Characteristic (n=2902) (n=16564) (n=727) (n=3019) (n=873) (n=3624) (n=324) (n=1213)
Sex, n(%)
   Female 1315 (45.3%) 6178 (37.3%) 205 (28.2%) 711 (23.6%)
   Male 1587 (54.7%) 10386 (62.7%) 522 (71.8%) 2308 (76.4%)
Age at Enrollment, median 24 (22, 26) 38 (32, 45) 25 (23, 31) 40 (34, 46) 24 (22, 26) 36 (31, 42) 25 (23, 31) 39 (34, 44)
Age at Diagnosis, median 22 (20, 24) 36 (31, 43) 22 (20, 24) 36 (31, 42) 22 (21, 24) 34 (29, 40) 22 (21, 24) 35 (30, 40)
Years Between Diagnosis and Enrollment, median 0.9 (0.1, 4.4) 0.3 (0.1, 1.8) 2.5 (0.2, 9.6) 0.8 (0.2, 5.8) 0.5 (0.1, 3.1) 0.3 (0.1, 1.7) 1.2 (0.2, 9.0) 0.9 (0.2, 6.0)
Probable Route of Infection, n(%)
   Heterosexual 928 (32.0%) 4660 (28.1%) 188 (25.9%) 826 (27.4%)
   MSM 873 (30.1%) 3624 (21.9%) 324 (44.6%) 1213 (40.2%)
   Other 86 (3.0%) 278 (1.7%) 64 (8.8%) 350 (11.6%)
   Unknown 1015 (35.0%) 8002 (48.3%) 151 (20.8%) 630 (20.9%)
Clinical Stage at Enrollment, n(%)
   AIDS 818 (28.2%) 5836 (35.2%) 57 (7.8%) 431 (14.3%) 290 (33.2%) 1726 (47.6%) 19 (5.9%) 166 (13.7%)
   Not AIDS 2007 (69.2%) 10307 (62.2%) 670 (92.2%) 2588 (85.7%) 567 (64.9%) 1829 (50.5%) 305 (94.1%) 1047 (86.3%)
   Unknown 77 (2.7%) 421 (2.5%) 0 (0.0%) 0 (0.0%) 16 (1.8%) 69 (1.9%) 0 (0.0%) 0 (0.0%)
CD4 at Enrollment 255 (124, 422) 186 (73, 324) 389 (239, 539) 306 (132, 513) 302 (148, 475) 235 (87, 420) 384 (242, 528) 329 (1524 529)
   Missing CD4 at Enrollment, n(%) 305 (10.5%) 1764 (10.6%) 16 (2.2%) 58 (1.9%) 89 (10.2%) 439 (12.1%) 4 (1.2%) 19 (1.6%)

Abbreviations:

a

MSM, men who have sex with men

b

CCASAnet, Caribbean, Central and South America network for HIV epidemiology

c

VCCC, Vanderbilt Comprehensive Care Clinic, Nashville, TN, USA